Health Safety and Regulation of Nanomaterials
Understand the main nanomaterial hazards, WHO safety guidelines, and recommended exposure control strategies.
Summary
Read Summary
Flashcards
Save Flashcards
Quiz
Take Quiz
Quick Practice
Which exposure route for engineered nanomaterials is considered the most concerning based on animal studies?
1 of 11
Summary
Health Hazards and Safety Management of Engineered Nanomaterials
Introduction
Engineered nanomaterials are particles deliberately designed to have at least one dimension between 1 and 100 nanometers. While these materials offer significant technological benefits, they present unique health and safety challenges that differ from their larger bulk counterparts. This section covers the primary hazards associated with nanomaterials, strategies for controlling exposure, and the World Health Organization's guidelines for safe handling.
Primary Hazard Routes and Exposure Concerns
Nanomaterials can enter the body through multiple routes, but inhalation is recognized as the most significant concern for occupational exposure. Understanding why inhalation matters requires knowing what happens when these particles reach the lungs.
Inhalation as the Primary Hazard
When nanomaterials are inhaled, they can deposit deep within the lungs—particularly in the alveoli (the tiny air sacs where gas exchange occurs). Once there, these particles are small enough to cross cellular barriers and interact with intracellular structures. This ability to penetrate at the cellular level is what distinguishes nanomaterials from larger particles.
Animal studies have demonstrated that carbon nanotubes and nanofibers cause serious pulmonary (lung) effects including:
Pulmonary inflammation: The body's immune response causes tissue swelling and irritation
Granulomas: Clumps of immune cells that form around foreign particles
Fibrosis: Scarring of lung tissue that reduces lung function
Importantly, the pulmonary potency of carbon nanotubes and nanofibers is comparable to established occupational hazards like silica dust, asbestos, and ultrafine carbon black—materials that have long been regulated due to their serious health effects.
Other Exposure Routes
While inhalation is the primary concern, exposure can also occur through:
Dermal (skin) contact: Direct contact with nanomaterial solutions or powders
Ingestion: Accidental ingestion, though this is less common in occupational settings
However, current evidence for serious health effects from these routes is more limited than for inhalation. That said, the precautionary principle (explained below) suggests we should still implement protective measures for these routes.
Hazard Control Strategies
There are several approaches to managing nanomaterial hazards, ranging from most effective to least effective.
Elimination and Substitution
The most effective control strategy is elimination—simply not using the hazardous material at all. The next best approach is substitution—replacing the dangerous nanomaterial with a safer alternative. However, for many applications, these options are not feasible because the unique properties of the nanomaterial are essential to the product's function.
Modifying Nanoparticle Properties
When elimination or substitution isn't possible, researchers can alter the properties of nanomaterials to improve their safety profiles while retaining their useful characteristics. Key properties that can be modified include:
Size and shape: Changing particle dimensions
Surface charge: Altering electrical properties of the particle surface
Solubility: Making particles dissolve more readily
Agglomeration tendency: Whether particles clump together
By modifying these properties intelligently, scientists can sometimes reduce toxicity without losing the functionality that makes the nanomaterial valuable.
Operational Controls: Handling Methods
A straightforward practical control is changing how the material is handled. Handling nanomaterials as slurries (wet pastes) or suspensions (dispersed in liquid) rather than as dry powders dramatically reduces the generation of airborne dust. This simple change can substantially decrease inhalation exposure in many workplace settings.
WHO Guidelines: A Framework for Safe Nanomaterial Management
In 2017, the World Health Organization published comprehensive guidelines for protecting workers from potential risks of manufactured nanomaterials. These guidelines reflect a precautionary approach: they recommend reducing exposure to nanomaterials even when scientific evidence of adverse health effects is uncertain.
The Logic Behind Precaution
This precautionary stance is important to understand. With established occupational hazards like asbestos or silica, decades of epidemiological studies clearly documented health damage in workers. With nanomaterials, we don't yet have that long historical record. Rather than waiting for workers to develop diseases before implementing protections, WHO recommends implementing safety measures now—especially given that early animal studies suggest nanomaterials could be as harmful as known hazards.
Hazard Classification and Communication
All manufactured nanomaterials should be assigned hazard classes, according to WHO, to facilitate consistent risk management. The Globally Harmonized System of Classification and Labelling of Chemicals provides hazard information, though currently only for a limited number of nanomaterials.
Importantly, safety data sheets should be updated with nanomaterial-specific hazard information. If toxicological data are missing, this should be explicitly noted on the safety data sheet—a worker or safety professional should know what information is not available about a material they're handling.
Exposure Assessment: A Step-Wise Approach
Before implementing controls, organizations should understand the actual exposure levels in their workplace. WHO recommends a three-step assessment process:
Step 1: Evaluate Potential for Exposure Determine whether the nanomaterial could actually become airborne and be inhaled. This depends on the process (e.g., handling dry powder vs. liquid suspension), workplace conditions, and work practices.
Step 2: Conduct Basic Exposure Assessment If exposure is possible, perform initial measurements or observations to determine exposure levels. This might involve air sampling or reviewing how the material is currently being handled.
Step 3: Perform Comprehensive Assessment When the potential for exposure is significant, conduct more detailed assessment using standardized methods from the OECD (Organisation for Economic Co-operation and Development) or CEN (European Committee for Standardization).
Setting Exposure Limits
A crucial principle: in workplaces without regulatory occupational exposure limits (OELs) for a specific nanomaterial, exposure should be compared to at least the OEL for the bulk form of that material. This ensures that workers handling nanomaterials aren't less protected than those handling the larger version.
Control of Exposure: The Hierarchy of Controls
The cornerstone of WHO's recommendations is the hierarchy of controls—a ranked framework for eliminating or reducing hazards:
The Hierarchy, from Most to Least Effective
Elimination: Remove the hazard entirely (stop using the nanomaterial)
Substitution: Replace it with a less hazardous material
Engineering Controls: Modify the work environment to prevent exposure (e.g., ventilation systems, enclosures)
Administrative Controls: Change work practices (e.g., training, exposure procedures)
Personal Protective Equipment (PPE): Provide workers with respirators or protective clothing
This hierarchy reflects an important principle: PPE should be the last resort, not the first line of defense. Why? Because PPE depends on proper fit-testing, maintenance, and consistent correct use by workers—factors that are often unreliable in real-world settings. Engineering controls, by contrast, work automatically and don't depend on worker compliance.
Practical Implementation
When toxicological information is limited, WHO recommends implementing the highest level of controls (engineering controls) even if current exposure appears low. This precautionary stance reflects the uncertainty about what exposure level is actually safe.
When better toxicological data become available, a more tailored approach can be used—controls can be scaled to match the actual hazard.
Preventing Inhalation Exposure
WHO makes a strong emphasis on preventing inhalation exposure, the primary hazard route. Specific recommendations include:
Local exhaust ventilation: Capture contaminants at the source before they disperse into the workplace air
If ventilation is unavailable: Use respiratory protective equipment with proper fit-testing
The fit-testing requirement is important—an ill-fitting respirator provides little protection.
Preventing Dermal Exposure
To prevent skin contact, WHO recommends standard occupational hygiene measures:
Regular cleaning of work surfaces
Use of appropriate gloves when handling nanomaterials
The evidence base for these measures is weaker than for inhalation controls (hence these are "conditional" rather than "strong" recommendations), but they represent sensible precautions.
Summary: Key Takeaways
Engineered nanomaterials represent both opportunities and challenges. The key points for safe management are:
Inhalation is the primary concern, because nanomaterials can reach deep into lungs and cross cellular barriers
Properties matter: Carbon nanotubes and nanofibers are as concerning as established hazards like silica
Multiple control strategies exist: from modifying the material itself to changing handling procedures
The WHO advocates precaution: implement protections even when uncertainty exists about health effects
The hierarchy of controls should guide decisions: prioritize engineering controls over PPE
Assessment must happen first: understand your workplace's exposure before choosing controls
By following these principles, workplaces can realize the benefits of nanomaterial technology while protecting worker health and safety.
Flashcards
Which exposure route for engineered nanomaterials is considered the most concerning based on animal studies?
Inhalation
What are three pulmonary conditions associated with exposure to carbon nanotubes and nanofibers in animal studies?
Pulmonary inflammation
Granulomas
Fibrosis
The pulmonary potency of carbon nanotubes and nanofibers is comparable to which three substances?
Silica
Asbestos
Ultrafine carbon black
In what physical form should nanomaterials be handled to reduce dust exposure compared to dry powders?
Slurries or suspensions
According to the World Health Organization (WHO), why should exposure to manufactured nanomaterials be reduced even when scientific evidence of health effects is uncertain?
The precautionary principle
Under the hierarchy of controls principle for nanomaterial safety, what type of controls are prioritized over personal protective equipment (PPE)?
Engineering controls
What action does the WHO advise for all manufactured nanomaterials to facilitate better risk management?
Assigning hazard classes
What are the three steps in the WHO's proposed step-wise inhalation exposure assessment for nanomaterials?
Evaluate potential for exposure
Conduct basic exposure assessment
Perform comprehensive assessment using OECD or CEN methods
What is the specific order of the hierarchy of controls endorsed by the WHO for nanomaterials?
Eliminate the source
Engineering controls
Administrative controls
Personal protective equipment (PPE)
What specific engineering control does the WHO recommend when inhalation exposure to nanomaterials is high or toxicological data are scarce?
Local exhaust ventilation
In workplaces lacking regulatory OELs for nanomaterials, what should the exposure be compared to?
A proposed OEL at least as protective as the legal OEL for the bulk form of the material
Quiz
Health Safety and Regulation of Nanomaterials Quiz Question 1: Animal studies of inhaled carbon nanotubes and nanofibers have demonstrated which of the following pulmonary effects?
- Pulmonary inflammation, granuloma formation, and fibrosis (correct)
- Only acute bronchoconstriction
- Chronic obstructive pulmonary disease without inflammation
- Reduced lung capacity without tissue damage
Health Safety and Regulation of Nanomaterials Quiz Question 2: According to WHO’s hierarchy of controls for nanomaterial safety, which measure is applied as the last line of defense?
- Personal protective equipment (PPE) (correct)
- Engineering controls such as local exhaust ventilation
- Administrative controls like work‑practice procedures
- Elimination of the nanomaterial source
Health Safety and Regulation of Nanomaterials Quiz Question 3: What does the World Health Organization advise assigning to all manufactured nanomaterials to facilitate risk management?
- Hazard classes (correct)
- Specific occupational exposure limits
- Standardized safety labels
- Manufacturing quotas
Health Safety and Regulation of Nanomaterials Quiz Question 4: Which property alteration is recommended to improve a nanomaterial's toxicological profile while retaining its functionality?
- Changing particle size (correct)
- Changing color
- Altering magnetic susceptibility
- Modifying density
Health Safety and Regulation of Nanomaterials Quiz Question 5: What does the WHO precautionary guideline recommend when scientific evidence of adverse health effects from nanomaterials is uncertain?
- Reduce exposure as a precaution (correct)
- Increase exposure to gather more data
- Maintain current exposure levels
- Ignore exposure concerns
Health Safety and Regulation of Nanomaterials Quiz Question 6: After evaluating the potential for exposure, what does WHO recommend as the next step in its step‑wise inhalation exposure assessment for nanomaterials?
- Conduct a basic exposure assessment (correct)
- Perform a comprehensive assessment using OECD or CEN methods
- Apply specific occupational exposure limit values
- Immediately implement engineering controls
Animal studies of inhaled carbon nanotubes and nanofibers have demonstrated which of the following pulmonary effects?
1 of 6
Key Concepts
Nanomaterial Safety and Health Risks
Inhalation hazard of nanomaterials
Dermal exposure to nanomaterials
Nanoparticle toxicology
Occupational exposure limits for nanomaterials
Regulatory and Safety Frameworks
World Health Organization nanomaterial guidelines
Hierarchy of controls
Globally Harmonized System of Classification and Labelling (GHS) for nanomaterials
Engineering controls for nanomaterial safety
Engineered Nanomaterials
Engineered nanomaterials
Definitions
Engineered nanomaterials
Materials intentionally designed at the nanoscale with specific properties for diverse applications.
Inhalation hazard of nanomaterials
Health risks arising from breathing airborne nanoparticles, including pulmonary inflammation, granulomas, and fibrosis.
Dermal exposure to nanomaterials
Potential adverse effects from skin contact with nanoparticles and associated protective measures.
World Health Organization nanomaterial guidelines
WHO recommendations for protecting workers from the potential risks of manufactured nanomaterials.
Hierarchy of controls
A safety framework that prioritizes elimination, engineering controls, administrative controls, and personal protective equipment.
Globally Harmonized System of Classification and Labelling (GHS) for nanomaterials
International system for communicating chemical hazards, with specific provisions for nanomaterials.
Occupational exposure limits for nanomaterials
Regulatory or proposed limits on the concentration of nanomaterials to which workers may be exposed.
Nanoparticle toxicology
The study of the mechanisms and health effects of toxicity caused by nanoscale particles.
Engineering controls for nanomaterial safety
Technical measures such as local exhaust ventilation used to reduce airborne nanoparticle exposure.